ArticleFrontiers in big data2022
An Experimental Study on the Scalability of Recent Node Centrality Metrics in Sparse Complex Networks.
Article in Frontiers in big data, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 11 citations in OpenAlex.
- Guiding prevention initiatives by applying network analysis to systems maps of adverse childhood experiences and adolescent suicide.Network science (Cambridge University Press) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Node centrality measures are among the most commonly used analytical techniques for networks. They have long helped analysts to identify "important" nodes that hold power in a social context, where damages could have dire consequences for transportation applications, or who should be a focus for prevention in epidemiology. Given the ubiquity of network data, new measures have been proposed, occasionally motivated by emerging applications or by the ability to interpolate existing measures. Before analysts use these measures and interpret results, the fundamental question is: are these measures likely to complete within the time window allotted to the analysis? In this paper, we comprehensively examine how the time necessary to run 18 new measures (introduced from 2005 to 2020) scales as a function of the number of nodes in the network. Our focus is on giving analysts a simple and practical estimate for sparse networks. As the time consumption depends on the properties in the network, we nuance our analysis by considering whether the network is scale-free, small-world, or random. Our results identify that several metrics run in the order of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.